AU2001288764A1 - Chlamydial peptides and their mimics in demyelinating disease - Google Patents

Chlamydial peptides and their mimics in demyelinating disease

Info

Publication number
AU2001288764A1
AU2001288764A1 AU2001288764A AU8876401A AU2001288764A1 AU 2001288764 A1 AU2001288764 A1 AU 2001288764A1 AU 2001288764 A AU2001288764 A AU 2001288764A AU 8876401 A AU8876401 A AU 8876401A AU 2001288764 A1 AU2001288764 A1 AU 2001288764A1
Authority
AU
Australia
Prior art keywords
mimics
demyelinating disease
chlamydial
peptides
chlamydial peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288764A
Inventor
Alan P. Hudson
Derek C. Lenz
Robert H. Swanborg
Judith A. Whittum-Hudson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Original Assignee
Wayne State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wayne State University filed Critical Wayne State University
Publication of AU2001288764A1 publication Critical patent/AU2001288764A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001288764A 2000-09-06 2001-09-06 Chlamydial peptides and their mimics in demyelinating disease Abandoned AU2001288764A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23045300P 2000-09-06 2000-09-06
US60/230,453 2000-09-06
US30186001P 2001-07-02 2001-07-02
US60/301,860 2001-07-02
PCT/US2001/027533 WO2002020047A2 (en) 2000-09-06 2001-09-06 Chlamydial peptides and their mimics in demyelinating disease

Publications (1)

Publication Number Publication Date
AU2001288764A1 true AU2001288764A1 (en) 2002-03-22

Family

ID=26924239

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288764A Abandoned AU2001288764A1 (en) 2000-09-06 2001-09-06 Chlamydial peptides and their mimics in demyelinating disease

Country Status (3)

Country Link
US (1) US20040038920A1 (en)
AU (1) AU2001288764A1 (en)
WO (1) WO2002020047A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004113374A2 (en) * 2003-06-17 2004-12-29 Intercell Ag Chlamydia pneumoniae antigens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194425A (en) * 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
WO1999037315A1 (en) * 1998-01-27 1999-07-29 Bai Jane Pei Fan Chemical derivatives of autoantigens and autoimmune-suppressive peptides and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
US20040038920A1 (en) 2004-02-26
WO2002020047A2 (en) 2002-03-14
WO2002020047A9 (en) 2003-08-21
WO2002020047A3 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
AU2001255436A1 (en) Protein expression system arrays and use in biological screening
AU2001251114A1 (en) Enhancing contrast in biological imaging
GB9911675D0 (en) In vitro peptide or protein expression library
AU2944300A (en) Plastic zipper improved in durability
AU6347496A (en) Engineering protein posttranslational modification in transg enic organisms
AU2001244602A1 (en) Drugs retained in target tissue over long time
AU3117400A (en) Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
GB9918155D0 (en) Proteins and peptides
AU2000275748A1 (en) Hla-a2.1 binding peptides and their uses
AU2001274566A1 (en) Novel protein and dna thereof
AU2001288764A1 (en) Chlamydial peptides and their mimics in demyelinating disease
GB0026134D0 (en) Peptides and their use
AU2001251665A1 (en) Medicine response assay in respiratory disease
AU2136401A (en) P450rai-2 and related proteins
AU3263601A (en) Heme proteins hemat-HS and hemat-BS and their use in medicine and microsensors
GB0020952D0 (en) Genes and proteins and their uses
AU5553000A (en) Insecticidal and nematicidal proteins
AU2001245367A1 (en) Human transporter genes and proteins encoded thereby
AU2001241446A1 (en) Human transporter proteins and polynucleotides encoding the same
AU2001288544A1 (en) 52991, a human transporter protein and uses therefor
AU2001275337A1 (en) Novel human transporter proteins and polynucleotides encoding the same
AU2002329977A1 (en) In vitro protein translation microarray device
EP1302477A4 (en) Peptide fructose and complex thereof with binding protein
AU2000274739A1 (en) Hla binding peptides and their uses